3Stern MP.Diabetes and cardiovascular disease:the "common soil" hypothesis[J].Diabetes,1995,44(4):369-374.
4Pepys MB,Baltz ML.Acute phase proteins with special reference to C-reactive protein and related proteins(pentaxins)and serum amyloid a protein[J].Adv Immunol,1983,34:141-212.
9Torzewski J,Torzewski M,Bowyer DE,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998,18(9):1386-1392.
10Schieffer B,Schieffer E,Hilfiker-kleiner D,et al.Expression of angiotensin Ⅱ and interleukin-6 in human coronary atherosclerotic plaques potential implications for inflammation and plaque instability[J].Circulation,2000,101(12):1372-1378.
3The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin dependent diabetes mellitus. N Engl J Med,1993,329:977-986.
4UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 1998,352.:837-853.
5Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complica tions in Japanese patients with non-insulin-dependent diabetes mellitus; a randomized prospective 6-year study. Diabetes Res Clin Pratt,1995,28 ; 103-117.
6Turner RC, Milns H, Neil HA, et al. Risk factors for coronary artery disease in non insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS.. 23). BMJ, 1998, 316:823-828.
7The ADVANCE collaborative group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med,2008,358:2560 2572.
8The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med,2008,358.-2545-2559.
9Holman RR, Sanjoy KP, Bethel MA, et al. 10 Year Follow-up of intensive glucose control in type 2 diabetes. N Engl J Med, 2008,359 : 1577-1589.
10Bakris GL, Ruilope LM, McMorn SO, et al. Rosiglitazone reduces microalbuminuria and blood pressure independently of glycemia in type 2 diabetes patients with microalbuminuria. J Hypertens, 2006,24:2047-2055.
